ROACCUTANE isotretinoin 10mg soft capsules (Neon, UK)
Section 19A approved medicine
ROACCUTANE isotretinoin 10mg soft capsules (Neon, UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
ISOTRETINOIN-WGR isotretinoin 10mg capsule - soft blister pack - ARTG 432371
ISOTRETINOIN LUPIN isotretinoin 10 mg capsule blister pack - ARTG 324225
ISOTRETINOIN Gx isotretinoin 10mg capsule blister pack - ARTG 240732
APO-ISOTRETINOIN isotretinoin 10mg capsule - soft blister pack - ARTG 190940
ISOTRETINOIN LUPIN isotretinoin 10 mg capsule blister pack - ARTG 324225
ISOTRETINOIN Gx isotretinoin 10mg capsule blister pack - ARTG 240732
APO-ISOTRETINOIN isotretinoin 10mg capsule - soft blister pack - ARTG 190940
Indication(s)
Isotretinoin is indicated for the treatment of severe cystic acne. A single course of therapy has been shown to result in complete and prolonged remission of disease in many patients.
If a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug.
Because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.
Images
